Vanguard Capital Management Acquires 5.01% Stake in Kura Oncology Inc

Vanguard Capital Management LLC filed a Schedule 13G on April 30, 2026, disclosing a new 5.01% ownership stake in Kura Oncology Inc (KURA). As of the event date of March 31, 2026, Vanguard reported beneficial ownership of 4,428,812 shares of Common Stock. This represents a significant increase from a previous ownership level of 0.0%. The filing indicates that Vanguard Capital Management holds sole dispositive power over all 4,428,812 shares, while possessing sole voting power over 643,127 shares. The shares were acquired in the ordinary course of business, and the filing includes interests held by various affiliates, including Vanguard Asset Management Limited and Vanguard Global Advisers, LLC. The reporting person certified that the securities were not acquired for the purpose of changing or influencing the control of the issuer. This position establishes Vanguard as a major institutional shareholder in the La Jolla-based biopharmaceutical company.